Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB IBB AMZN TSLA ALXN ILMN WYNN AMGN GMCR SLXP COST GILD AAPL CELG WDC SNDK INTU
Nyse: ACT V IVV AGN GS LMT PXD SPG FDX IBM MMM TWC CMI GD APD NOC BA WLP TMO EW
New Highs: REGN IBB MCK ALXN SPG ORLY WHR BCR MMM IDXX GD EW UNP SLG GILD PANW AAPL CELG CLX TRV

The Hot Industries

Biotechnology 4
REIT - Retail 2
Railroads 1

The Hot Sectors

Healthcare 7
Consumer Goods 3
Financial 3

ILMN Stock Chart


ILMN
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

3,000
Monthly

Website:

http://www.illumina.com

ILMN Illumina Inc.

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

favicon

Fate Therapeutics (FATE) Crumbles: Stock Tumbles by 10.6%

24 Oct 2014, 4:47 amFate Therapeutics has been witnessing a flat trend in its current year estimates and its share price has been falling for past 1 month
favicon

Merrimack Pharmaceuticals (MACK) Looks Strong: Stock Up 8.6%

24 Oct 2014, 4:35 amMerrimack Pharmaceuticals (MACK) was a big mover last session, as the company saw its shares jump nearly 9% on the day
favicon

ZIOPHARM Oncology (ZIOP) Jumps: Stock Moves Up 8.5%

24 Oct 2014, 12:28 amZIOPHARM Oncology, Inc. (ZIOP) was a big mover last session, as its shares rose nearly 6% on the day.
favicon

Will Illumina (ILMN) Continue to Surge Higher?

23 Oct 2014, 8:45 amWill Illumina (ILMN) Continue to Surge Higher?
favicon

NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4%

23 Oct 2014, 5:54 amNewLink Genetics Corporation (NLNK) was a big mover last session, as the company saw its shares rise by over 15% on the day.
favicon

Illumina (ILMN) Looks Strong: Stock Gains 9.2%

22 Oct 2014, 4:43 amIllumina (ILMN) was a big mover last session, as the company saw its shares jump over 9% on the day
favicon

Critical Alerts For GoPro, NQ Mobile, SunEdison, Illumina and Qihoo 360 Technology Released By InvestorsObserver

21 Oct 2014, 7:45 amCHICAGO, Oct. 21, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GPRO, NQ, SUNE, ILMN and QIHU. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note:...
favicon

Vital Therapies (VTL) in Focus: Stock Adds 7.9% in Session

21 Oct 2014, 12:38 amVital Therapies, Inc. (VTL) was a big mover last session, as its shares rose almost 8% on the day.
favicon

NewLink Genetics Corp. (NLNK) Jumps: Stock Rises 7.1%

21 Oct 2014, 12:35 amNewLink Genetics Corporation (NLNK) was a big mover last session, as its shares rose over 7% on the day.
favicon

Why Illumina (ILMN) Stock Is Gaining in After-Hours Trading Today

20 Oct 2014, 3:29 pmNEW YORK (TheStreet) -- Illumina shares are up 9.75% to $180.50 in after-hours trading on Monday after the company reported third quarter earnings results ahead of analysts expectations. The San Diego-based life sciences diagnostic company reported third quarter earnings of 77 cents per diluted share, well ahead of the 56 cents per diluted share analysts were expecting for the period. Must Read ...